Evidence map›Paper›PMID 29183888›Full record

ArticleBlood2018

Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes.

Anuhya Kommalapati, Sri Harsha Tella, Martin Durkin, Ronald S Go, Gaurav Goyal

Abstract readLetter
In one paragraph

Article in Blood, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. A case report of histiocytic sarcoma mimicking acute pericarditis.European heart journal. Case reports · 2025
    Article
  16. PAK2-driven cytoskeleton-endosome dynamics control macrophage hyperphagia and SIRPA engagement.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Histiocytic Sarcoma: A Review and Update.International journal of molecular sciences · 2025
    Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anuhya KommalapatiDepartment of Internal Medicine, University of South Carolina School of Medicine, Columbia, SC.
Sri Harsha TellaDepartment of Internal Medicine, University of South Carolina School of Medicine, Columbia, SC.ORCID 0000-0001-8878-1283
Martin DurkinPalmetto Health USC Medical Group, Columbia, SC; and.
Ronald S GoDivision of Hematology, Mayo Clinic, Rochester, MN.
Gaurav GoyalDivision of Hematology, Mayo Clinic, Rochester, MN.ORCID 0000-0001-6148-5177

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAgedAged, 80 and overEpidemiological MonitoringFemaleHistiocytic SarcomaHumansIncidenceMaleMiddle AgedSurvival AnalysisUnited StatesYoung Adult

Identifiers

PMID29183888
PMCPMC5757688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.